UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039633
Receipt number R000045200
Scientific Title Safety and usefulness of the use of solid soap in patients with atopic dermatitis, seborrheic dermatitis and asteatotic eczema
Date of disclosure of the study information 2020/02/28
Last modified on 2020/02/28 16:41:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and usefulness of the use of solid soap in patients with atopic dermatitis, seborrheic dermatitis and asteatotic eczema

Acronym

Safety and usefulness of the use of solid soap in patients with atopic dermatitis, seborrheic dermatitis and asteatotic eczema

Scientific Title

Safety and usefulness of the use of solid soap in patients with atopic dermatitis, seborrheic dermatitis and asteatotic eczema

Scientific Title:Acronym

Safety and usefulness of the use of solid soap in patients with atopic dermatitis, seborrheic dermatitis and asteatotic eczema

Region

Japan


Condition

Condition

atopic dermatitis, seborrheic dermatitis and asteatotic eczema with symptoms on the face

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigated the safety and usefulness of transparent solid soaps in patients with mild to moderate atopic dermatitis and seborrheic dermatitis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

safety and usefulness

Key secondary outcomes

Subject background
Usage log
Subject questionnaire


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Subjects use test facial soap instead of regular soap for four weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients with skin diseases described in Condition
2.Japanese over 20 years old when obtaining consent
3.On participation in this study, Patients who have been given sufficient explanations, have gotten their full understanding and written consent.
4.Outpatient
5.Patients who is deemed appropriate by the Research Responsibility (charge) doctor.

Key exclusion criteria

1.Patients with skin diseases described in without Condition
2.Patients have inappropriate eczema (emarkable Erythema or erosion, etc...)
3.Patients have an allergy in ingredient of test soap.
4.Pregnant or possibly pregnant woman
5.Patients who is deemed inappropriate by the Research Responsibility (charge) doctor.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yoko
Middle name
Last name Funasaka

Organization

Nippon Medical School

Division name

Dermatology

Zip code

113-8602

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

TEL

0338222131

Email

funasaka@nms.ac.jp


Public contact

Name of contact person

1st name Hidehisa
Middle name
Last name Saeki

Organization

Nippon medical school hospital

Division name

Dermatology

Zip code

113-8602

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

TEL

0338222131

Homepage URL


Email

h-saeki@nms.ac.jp


Sponsor or person

Institute

Nippon medical school hospital

Institute

Department

Personal name



Funding Source

Organization

MOCHIDA HEALTHCARE CO.,LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Takano Medical Clinic.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medical School Hospital IRB

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

Tel

0338222131

Email

clinicaltrial@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 25 Day

Date of IRB

2018 Year 01 Month 25 Day

Anticipated trial start date

2018 Year 04 Month 25 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 02 Month 28 Day

Last modified on

2020 Year 02 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045200


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name